Edesa Biotech, Inc. Annual Depreciation, Depletion and Amortization in USD from 2012 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Edesa Biotech, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2012 to 2024.
  • Edesa Biotech, Inc. Depreciation, Depletion and Amortization for the quarter ending December 31, 2024 was $43.1K, a 4.27% decline year-over-year.
  • Edesa Biotech, Inc. annual Depreciation, Depletion and Amortization for 2024 was $186K, a 1.41% increase from 2023.
  • Edesa Biotech, Inc. annual Depreciation, Depletion and Amortization for 2023 was $183K.
  • Edesa Biotech, Inc. annual Depreciation, Depletion and Amortization for 2017 was $179K, a 19.9% increase from 2016.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $186K +$2.58K +1.41% Oct 1, 2023 Sep 30, 2024 10-K 2024-12-13
2023 $183K Oct 1, 2022 Sep 30, 2023 10-K 2024-12-13
2017 $179K +$29.8K +19.9% Oct 1, 2016 Sep 30, 2017 10-K 2017-12-01
2016 $150K -$9.96K -6.24% Oct 1, 2015 Sep 30, 2016 10-K 2017-12-01
2015 $160K +$1.21K +0.76% Oct 1, 2014 Sep 30, 2015 10-K 2017-12-01
2014 $158K +$33.5K +26.8% Sep 1, 2013 Aug 31, 2014 10-K 2016-12-14
2013 $125K +$12.7K +11.3% Sep 1, 2012 Aug 31, 2013 10-K 2015-12-14
2012 $112K Sep 1, 2011 Aug 31, 2012 10-K 2014-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.